Table:
begin	end	state
1	5	non-cytoplasmic
6	29	transmembrane
30	36	cytoplasmic
37	106	non-cytoplasmic
107	125	transmembrane
126	130	cytoplasmic
131	150	transmembrane
151	155	non-cytoplasmic
156	179	transmembrane
180	190	cytoplasmic
191	197	non-cytoplasmic
198	199	cytoplasmic
200	227	transmembrane
228	278	cytoplasmic
279	305	transmembrane
306	310	non-cytoplasmic
311	330	transmembrane
331	357	cytoplasmic
358	378	transmembrane
379	412	non-cytoplasmic
413	419	transmembrane
420	424	non-cytoplasmic
425	443	transmembrane
444	448	cytoplasmic
449	467	transmembrane
468	472	non-cytoplasmic
473	497	transmembrane
498	502	cytoplasmic
503	528	transmembrane
529	532	non-cytoplasmic
533	552	transmembrane
553	587	cytoplasmic
588	611	transmembrane
612	630	non-cytoplasmic
631	649	transmembrane
650	664	cytoplasmic

Input:
>GFF2296 FitnessBrowser__Phaeo:GFF2296
MSARLSPQSATVWGLILVTILLGWFGRDLSKALDARWLIKVPSSWVLPLKGHISSAMTWL
VEDAAIGPISFTDVTRAVAWLIEQPYELMLSLLANGFFVSSGPGAEALLPAASWIAVTAA
VIALGHYCRNWGLAAVAGACFAYLAVFGQWDSAMVTLASVLIAVPIGAGGGLLTGIWAYR
HPVGERILSPLLDLMQTIPIFAYLVPILFMFGFGPVSALVATIIYATPPMIRVTILALKS
VDPEILDFGRMAGTTPRQLMWRVLVPSASQSLMVGVNQVIMLTLNMVIIASMIGAGGLGF
DVLAALRRLDIGAGFEAGIAIVVLAIAVDRLSQAFAERMGQVHHIAPGSKATRHKRTVLV
LSLLIITWGLGRFSPLLLQYPISQTITTGDFWSETVKYLNVNYFDAFEAVKVFFLHWFML
PIKKTLLGIPWPWAVAMLTLVGWRAGGLRLALMCGSMSTLIAFSGLWAKAMVTVYLCGAS
VILATLIGVPLGVLAALNKRAGVAIGLFIDTLQTLPSFVYLIPVVMLFRVGDFTAMIAIV
LYALAPAVRYAAHGMRSVSGELIEAGLVSGCTRWQLLRMVRLPMALPEILLGINQTIMLA
LSMLVITALVGTRDLGQEVYIALTKADTGRGLVAGLAIAFIAIIADRLVNAGARGARIRF
GLET

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server